Logo
Premium Retiring
  • Investing
  • World News
  • Politics
  • Stock
  • Editor’s Pick
Stock

Twillio stock soars 20% on record Q3 results and strong AI-driven outlook

Stock

Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

Stock

Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

Stock

Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

Stock

Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

Stock

Weekly wrap: Trump-Xi truce talks, trillion-dollar milestones, and tech power plays

Investing

Ford stock C&H pattern points to a surge to $20 as catalysts rise

Skip to content
#
Categories Editor's Pick

Down 37% from 2022 high, is the Yes Bank share price a bargain?

Author April 7, 2023

Yes Bank (NSE: YESBANK) share price is hovering near its lowest level since November last year as the outlook of the Indian

#
Categories Editor's Pick

Is Costco stock a safe bet as a slowdown in consumer spending weighs on sales?

Author April 7, 2023

Costco Wholesale Corporation (NASDAQ: COST) ended in the red on Thursday after reporting its first decline in monthly same-store sales in about

Posts pagination

1 … 599 600







    Get Smarter with Your Money – Sign Up for Free Financial Tips!





    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    LATEST

    • Recent Posts
    #

    Twillio stock soars 20% on record Q3 results and strong AI-driven outlook

    Twilio Inc. shares soared Friday after the cloud communications company reported record...

    #

    Is Nvidia next? Why is China lifting its ban on certain Nexperia chips

    China has taken a significant step toward easing tensions in the global semiconductor supply chain...

    #

    Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash

    Pfizer has escalated its fight for obesity biotech Metsera by filing suit against both Metsera and...

    #

    Berkshire Hathaway delivers blowout Q3 profit as Buffett’s cash mountain keeps growing

    Berkshire Hathaway delivered a robust blowout in its Q3 2025 earnings, showcasing another strong...

    #

    Inside big tech’s $400 billion AI race: brilliant strategy or bubble waiting to burst?

    Big Tech has poured roughly $380-400 billion into AI infrastructure this year, fueling a race to...

    #

    Weekly wrap: Trump-Xi truce talks, trillion-dollar milestones, and tech power plays

    This week was packed with historic milestones and high-stakes moves across business and...

    • Email Whitelisting
    • Terms and Conditions
    • Privacy Policy
    • Contacts
    • About us

    Disclaimer: PremiumRetiring.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 PremiumRetiring.com All Rights Reserved.